- Nachrichtendetail
-
26.04.2024 15:02:59 - dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AMGEN INC. DL-,0001 | 867900 | Xetra | 280,250 | 28.05.24 13:38:20 | -6,150 | -2,15% | 279,800 | 280,550 | 283,400 | 286,400 |
